The results showed a linear relationship between the prevalence of PSCI and the quartile of baseline serum galectin-3 levels in AIS patients: the prevalence of PSCI increased with the increase of serum galectin-3 levels (p < 0.001). The gene discussed is LGALS3; the disease is androgen insensitivity syndrome.